Table 1.
Parameter | Total (n = 93) | SAE1 expression level | P Value | |
---|---|---|---|---|
High n = 65 |
Low n = 28 |
|||
Age (years) | ||||
≥ 60 | 67 | 45 | 22 | 0.357 |
< 60 | 26 | 20 | 6 | - |
Gender | ||||
Male | 59 | 43 | 16 | 0.408 |
Female | 34 | 22 | 12 | |
Tumor size | ||||
≥ 5 | 60 | 42 | 18 | 0.976 |
< 5 | 33 | 23 | 10 | |
Pathological type | ||||
Infiltrating | 54 | 39 | 15 | 0.865 |
Elevated | 7 | 5 | 2 | |
Ulcerative | 30 | 20 | 10 | |
Grade | ||||
I-II | 40 | 32 | 8 | 0.065 |
III | 53 | 33 | 20 | |
TNM stage | ||||
I-II | 35 | 20 | 15 | 0.029* |
III-IV | 56 | 44 | 12 | |
Vascular invasion | ||||
No | 65 | 41 | 24 | 0.029* |
Yes | 28 | 24 | 4 | |
Nerve invasion | ||||
No | 79 | 53 | 26 | 0.215 |
Yes | 14 | 12 | 2 | |
Overall survival | ||||
Survive | 33 | 12 | 21 | 0.013* |
Die | 60 | 37 | 23 |
†High and low expression was determined as total immunohistochemistry scores of 0–3 and 3–12 respectively
*P < 0.05 was identified as statistically significant